News Releases

News and information from The Leukemia & Lymphoma Society

More than 20 Years Helping Cancer Patients and Saving Lives

See multimedia release here.  RYE BROOK, N.Y. (August 8, 2017) – Where can I get good information about my cancer and treatments? Should I get a second opinion? Is there anyone I can talk with who has been through this? Where can I get financial assistance to help cover the cost of my treatment? How do I talk with my loved ones and children about my disease? These are just a few of the hundreds of questions...

LLS Applauds Another Advance for Blood Cancer Patients

August 3, 2017 (Rye Brook, NY)  - The Leukemia & Lymphoma Society (LLS) applauds the  U.S. Food and Drug Administration (FDA) approval today of CPX-351 (VyxeosTM), an innovative combination of two chemotherapy drugs being used to treat two high-risk subgroups of acute myeloid leukemia (AML) patients. After more than four decades of little progress in treating AML, this approval marks the third drug appr...

FDA Approves New Targeted Therapy for AML

Rye Brook, N.Y. (August 1, 2017) – Today marks another significant advance in the offensive against acute myeloid leukemia (AML), one of the most deadly blood cancers that takes more than 10,000 lives in the U.S. each year. The Leukemia & Lymphoma Society (LLS) applauds The U.S. Food & Drug Administration’s approval today of a new targeted therapy, enasidenib (IDHIFA®), for patients with AML, who ha...

‘SKINNY’ SENATE HEALTHCARE BILL WOULD THREATEN ACCESS TO CANCER TREATMENT

Rye Brook, N.Y. (July 26, 2017) – The U.S. Senate has initiated debate on the House-passed healthcare bill, and Senate leaders are indicating they intend to advance legislation they have termed ‘skinny repeal.’ This Senate proposal would increase premiums and cost-sharing for patients who purchase their own insurance plans, while leading some insurers to stop selling non-group coverage altogether, according to ...

Pages

Media Contact

Have media inquiries? Contact us between 9 a.m. and 5 p.m. ET, Monday through Friday: